Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Kina vs LevelUp Rx

Kina
Graded #118

Higher grade

vs+5.599999999999994
LevelUp Rx
Graded #246

Lower grade

The verdict

Kina takes it — 69.8/100 to 64.2/100.

Kina grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueKina +3
60
57
Dose & formulationEven
64
64
Clinical oversightKina +4
88
84
Labs & monitoringKina +11
64
53
FulfillmentKina +7
83
76
Contract termsKina +20
61
41
Kina · left barLevelUp Rx · right bar

The numbers

MetricKinaLevelUp Rx
WeighScore69.8/10064.2/100
GradeCC
Scorecard rank#118#246
Semaglutide$179/mo (starting dose, plus a separate fee, compounded)$150/mo (starting dose, compounded)
Tirzepatide$179/mo (starting dose, compounded)$250/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Kina

Graded #118 · C

Strengths

  • Menopause-specialized care — GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
  • Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
  • Verifiable LegitScript certification (seal ID 50917967)
  • GLP-1 from $179/month with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
  • Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake

Where it loses points

  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Built for women navigating menopause — less tailored if that is not your situation
  • A separate $50 physician consultation fee applies on top of the medication price
  • The compounding pharmacy partner is not named, and the full list of served states is not published
LevelUp Rx

Graded #246 · C

Strengths

  • Compounded semaglutide ($149.97/mo) and tirzepatide ($249.97/mo) on one platform
  • Flat monthly price that never changes with your dose
  • No-cost online consultation included with your order
  • LegitScript-certified; partner pharmacies named (DiRx and The DrugStore)
  • Free shipping with no insurance required

Where it loses points

  • Compounded only - no brand-name Wegovy, Zepbound, Ozempic or Mounjaro
  • No single prescribing medical group named; physicians listed only for CA, MA, RI and VT
  • State availability is confirmed during intake, not published as a list
  • Prescription sales are final once shipped; no returns on dispensed medication

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard